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a b s t r a c t
Apple latent spherical virus (ALSV)-based vectors experimentally infect a broad range of plant species
without causing symptoms and can effectively induce stable virus-induced gene silencing in plants. Here,
we show that pre-infection of ALSV vectors harboring part of a target viral genome (we called ALSV vector
vaccines here) inhibits the multiplication and spread of the corresponding challenge viruses [Bean yellow
mosaic virus, Zucchini yellow mosaic virus (ZYMV), and Cucumber mosaic virus (CMV)] by a homology-
dependent resistance. Further, the plants pre-infected with an ALSV vector having genome sequences of
both ZYMV and CMV were protected against double inoculation of ZYMV and CMV. More interestingly, a
curative effect of an ALSV vector vaccine could also be expected in ZYMV-infected cucumber plants,
because the symptoms subsided on subsequent inoculation with an ALSV vector vaccine. This may be due
to the invasion of ALSV, but not ZYMV, in the shoot apical meristem of cucumber.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Apple latent spherical virus (ALSV), originally isolated from an
apple tree in Japan and classiﬁed in the genus Cheravirus, is a
small spherical virus 25 nm in diameter, which is composed of a
two-segmented single-stranded RNA genome (RNA1 and RNA2)
and three coat proteins (Vp25, Vp20, and Vp24) (Li et al., 2000).
Although apple is the only known host of ALSV in nature, it has a
relatively wide range of experimental hosts including Arabidop-
sis thaliana, solanaceous plants (tobacco, tomato, potato, etc.),
cucurbits (cucumber, melon, squash, luffa, etc.), legumes (soy-
bean, azuki bean, pea, etc.), and fruit trees of the Rosaceae
family (apple, pear, peach, etc.) (Igarashi et al., 2009; Sasaki
et al., 2011). ALSV latently infects most of these host plants
without causing any obvious symptoms.
We previously reported that ALSV-based vectors effectively
induced stable virus-induced gene silencing (VIGS) of endogen-
ous genes for long periods in plants (Igarashi et al., 2009; Sasaki
et al., 2011; Yaegashi et al., 2007; Yamagishi and Yoshikawa,
2009). RNA silencing, a sequence-speciﬁc gene inactivation
mechanism ﬁrst reported in plants in 1990 (Napoli et al.,
1990), is induced by double-stranded RNA (dsRNA) and is
universally conserved in eukaryotes (Hannon, 2002). Infection
of plants by an RNA virus leads to synthesis of replicative dsRNA
by an RNA-dependent RNA polymerase. This dsRNA is degraded
into 21–25 nucleotide (nt) small interfering RNA (siRNA) by
Dicer (in plants, by Dicer-like). The siRNA is incorporated into an
RNA-induced silencing complex, resulting in degradation of RNA
with sequence complementary to the siRNA (Voinnet, 2005). In
addition, siRNA moves into adjacent cells, eventually leading to
its systemic spread (Mlotshwa et al., 2002; Voinnet and
Baulcombe, 1997). RNA silencing in plants can be compared to
the immune system in animals (Lecellier and Voinnnet, 2004;
Plasterk, 2002; Voinnet 2001), and RNA silencing plays an
important role as a defense mechanism against viral infection
in plants possessing no immune mechanism (Baulcombe, 2004;
Vance and Vaucheret, 2001; Waterhouse et al., 2001).
Zucchini yellow mosaic virus (ZYMV), belonging to the genus
Potyvirus, causes serious damage in cucurbit crops worldwide (Lecoq
and Desbiez, 2008). The virus is transmitted by aphids in a non-
persistent manner and causes symptoms including severe mosaic,
malformation of leaves and fruits, and withering of plant tissue,
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particularly in cucurbits (Lecoq and Desbiez, 2008). Though cucumber
mosaic disease is caused by a single infection by ZYMV, the disease
becomes severe on superinfection by two or three viruses including
ZYMV, Cucumber mosaic virus (CMV), and Watermelon mosaic virus
(WMV). To alleviate damage to crops by ZYMV, cross protection
using attenuated ZYMV is employed for control of the viral disease
(Kosaka and Fukunishi, 1997; Kosaka et al., 2006; Lecoq and Desbiez,
2008;Wang et al., 2006). Recently, an attenuated strain of ZYMV (ZYMV
2002), formulated as a biotic pesticide (CUBIO ZY-02), came on the
market and has been used in cucumber plants in Japan (Kosaka et al.,
2009). Development of attenuated plant pathogenic viruses, however, is
not always straightforward, and the production and screening of
such viruses require much time and labor, and may be difﬁcult,
depending on the target viral species. For that reason, the practical
use of attenuated viruses for control of viral diseases is very limited.
Furthermore, cross protection is often not sufﬁcient when the challenge
virus is phylogenetically distant from the primary virus, and thus, each
attenuated virus has to be established individually for each
virulent virus.
Ratcliff et al. (1999) reported RNA mediated cross-protection
between viruses, in which primary inoculation of Tobacco rattle
virus (TRV) vector with green ﬂuorescence protein (GFP) exhib-
ited cross protection against challenge inoculation of Potato
virus X (PVX) vector carrying GFP sequence, and also primary
inoculation of PVX vector with GFP induced cross protection
against challenge of Tobacco mosaic virus (TMV) with GFP. As
described above, ALSV is not only a virus with very weak
pathogenicity that latently infects most host plant species, but
it also efﬁciently induces systemic VIGS in infected plants. Here,
we report the production of recombinant ALSV, in which part of
a pathogenic virus (BYMV, ZYMV or CMV) gene was introduced
into an ALSV vector (we called an ALSV vector vaccine for the
sake of convenience in this paper), and that plants preinocu-
lated with this ALSV vector vaccine showed strong resistance
against challenge inoculation with a pathogenic virus as found
between TRV-GFP and PVX-GFP, and PVX-GFP and TMV-GFP
(Ratcliff et al., 1999). Furthermore, a curative effect can also be
expected in virus-infected plants because the disease symptoms
subside on subsequent inoculation with an ALSV vaccine.
Results
Preparation of ALSV vector vaccines harboring a genome fragment
of BYMV, ZYMV, or CMV
Two ALSV vectors (pEALSR1 and pEALSR2mL5mR5) devel-
oped earlier in our laboratory (Li et al., 2004) and
pEALSR2mL5mR5-3′MN, which was prepared by inserting a
multiple cloning site into the region outside the RNA2 ORF,
were used in this study (Fig. 1).
We ﬁrst constructed two types of ALSV vector vaccines harbor-
ing a 240-nt DNA fragment of the P3 region in BYMV-RNA
(Table 1). For one, a DNA fragment was inserted between the
Xho I and Bam HI sites, and for the other, the same DNA fragment was
inserted in the 3′-noncoding region of ALSV-RNA2 (Fig. 1).
These ALSV-RNA2 vectors with pEALSR1 were used to inoculate
Chenopodium quinoa to produce ALSV vector vaccines [ALSV-BY:P3
and ALSV-BY:P3()] (Table 1). These ALSV vector vaccines infected N.
benthamiana systemically without causing the appearance of any
symptoms.
With the aim of producing an ALSV vector vaccine harboring
a ZYMV genome fragment, we used pEALSR2mL5mR5 because
this vector has been found to induce effective VIGS of several
endogenous genes in herbaceous and fruit tree plants (Igarashi
et al., 2009; Sasaki et al. 2011). Each region of the ZYMV genome
was ampliﬁed by PCR (Table 1) and ligated into the Xho I and
Bam HI sites in pEALSR2mL5mR5, as shown in Fig. 1. The
resulting ALSV-RNA2 vectors were used to produce 10 ALSV
vector vaccine candidates against ZYMV (ALSV-Z:P1, ALSV-Z:Hc-
Pro, ALSV-Z:P3, ALSV-Z:Cl, ALSV-Z:NIa, ALSV-Z:Nib, ALSV-Z:CP,
ALSV-Z:CP117, ALSV-Z:CP66, and ALSV-Z:CP33) (Table 1). Simi-
larly, three ALSV vector vaccines provided with parts (207–
240 nt) of the CMV genome (corresponding to RNA1, 2, and 3;
namely ALSV-C:1a, ALSV-C:2a, and ALSV-C:CP) and an ALSV
vector vaccine with a ligated chimeric sequence of 150 nt each
of the ZYMV and CMV genome fragments (ALSV-ZC300) were
produced (Table 1). All these ALSV vector vaccines caused
systemic infection of cucumber plants without symptoms
(Table 1).
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Fig. 1. Construction scheme for ALSV vector vaccines against BYMV, ZYMV, and CMV. DNA fragments ampliﬁed from each viral genome were ligated into a cloning site of
ALSV-RNA2 vector (pEALSR2mL5mR5 or pEALSR2mL5mR5-3′MN) and used to inoculate C. quinoa to produce ALSV vaccines.
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Preventive effects of ALSV vector vaccines in N. benthamiana against
challenge inoculation with BYMV
The 3rd and 4th true leaves of N. benthamiana at the ﬁve-leaf
stage were inoculated with ALSV vector vaccines [ALSV-BY:P3 and
ALSV-BY:P3()] or control ALSV (wtALSV). After 4 days, the 5th
and 6th true leaves of pre-inoculated N. benthamiana plants at
the seven-leaf stage were challenged with BYMV-GFP for cross
protection tests. Though N. benthamiana inoculated with BYMV-
GFP did not show obvious symptoms, observation of GFP ﬂuores-
cence 15 days postinoculation (dpi) clearly showed that BYMV
was distributed in all 6th–10th leaves of plants inoculated with
BYMV-GFP only (BYMV plot) or wtALSV followed by BYMV-GFP
(wtALSV-BYMV plot) (Fig. 2A). On the other hand, GFP ﬂuores-
cence was not found in leaves of plants preinoculated with ALSV
vector vaccines (ALSV-BY:P3-BYMV and ALSV-BY:P3()-BYMV
plots) (Fig. 2A). The results were conﬁrmed by an enzyme-linked
immunosorbent assay (ELISA) in which BYMV accumulation was
not found in any leaves of plants preinoculated with ALSV-BY:P3
(Fig. 2B). Based on these results, ALSV vector vaccines containing a
part of the BYMV genome both between the Xho I and Bam HI sites
in the coding region and the Mlu I and Nde I sites in the 3′-
noncoding region of ALSV-RNA2 effectively inhibit the multiplica-
tion and spread of BYMV in N. benthamiana plants.
We analyzed the siRNA in leaves pre-inoculated with ALSV
vector vaccines to conﬁrm whether the inhibition and spread of
BYMV in pre-inoculated plants is due to VIGS. The RNA probe
complementary to the entire P3 region of BYMV genome was used
for northern blot hybridization. The results showed that the siRNA
were detected in leaves pre-inoculated with ALSV-BY:P3 and
ALSV-BY:P3()(Fig. 2C), indicating that ALSV vector vaccines
induced VIGS to target BYMV P3 region.
Cross protection of ALSV vector vaccines against ZYMV in cucumber
In a preliminary experiment with the aim of investigating how
time after inoculation with the ALSV vector vaccine affects the
induction of cross protection against the challenge virus, ALSV-Z:
CP was ﬁrst inoculated into two cotyledons of cucumber at the
cotyledon stage, then at 6, 9, and 12 days after inoculation, the 1st,
2nd, and 3rd true leaves, respectively, were challenge-inoculated
with an infectious clone of virulent ZYMV expressing GFP (ZYMV-
GFP). Because cross protection by ALSV-Z:CP was subsequently
observed in all the inoculated cucumber plants, in the following
tests, ﬁrst ALSV vector vaccines were inoculated into cotyledons
and then the 1st true leaf was challenge-inoculated with ZYMV-
GFP 6 days after the ﬁrst inoculation.
In the experimental plot without ALSV vector vaccine, with only
inoculation of ZYMV-GFP (ZYMV plot), and in the experimental plot
where ZYMV-GFP was challenge-inoculated after the ﬁrst inocula-
tion with wtALSV (wtALSV-ZYMV plot), disease symptoms includ-
ing chlorotic spots and interveinal chlorosis appeared around the
basal part of the 3rd true leaves approximately 12 days after
inoculation. In the 4th true leaves, mosaic symptoms were observed,
and in the 5th and subsequent true leaves, mosaic symptoms
appeared all over the leaves. In addition, in the ZYMV plot,
malformation and withering of leaves were observed accompanied
by severe mosaic symptoms, and the entire plant showed dwarﬁng
(Fig. 3A, B). In the wtALSV-ZYMV plot, although mosaic symptoms
were observed in the leaves, no severe withering of the plant
occurred (Fig. 3A, B). In contrast, in the plots where ZYMV-GFP
was challenge-inoculated after the ﬁrst inoculation with an ALSV
vector vaccine (ALSV-Z:P1-ZYMV, ALSV-Z:Hc-Pro-ZYMV, ALSV-Z:
P3-ZYMV, ALSV-Z:Cl-ZYMV, ALSV-Z:NIa-ZYMV, ALSV-Z:Nib-
ZYMV, and ALSV-Z:CP-ZYMV plots), no disease symptoms caused
by ZYMV were observed, similarly to the healthy plot and the
wtALSV plot (Fig. 3A and B).
GFP ﬂuorescence of plants in each plot was observed 14 days
after inoculation of ZYMV-GFP. Fluorescence was observed on
the veins of the inoculated 1st true leaves in the ZYMV and
wtALSV-ZYMV plots. In addition, in the second and subsequent
true leaves, GFP ﬂuorescence was detected in almost all regions
of the leaves (Table 2; Fig. 4A). In contrast, in the experimental
plots ﬁrst inoculated with an ALSV vector vaccine (ALSV-Z:P3,
ALSV-Z:Cl, ALSV-Z:NIa, ALSV-Z:Nib, or ALSV-Z:CP) followed by
challenge inoculation with ZYMV-GFP, GFP ﬂuorescence was
observed mainly on veins and their surrounding regions in the
1st and 2nd true leaves, or in a small region in the 3rd and 4th
leaves, but no ﬂuorescence was observed in the 5th or subse-
quent true leaves (Fig. 4A shows the results of the ALSV-Z:P3-
ZYMV and ALSV-Z:CP-ZYMV plots). However, in the plots with
a ﬁrst inoculation with ALSV-Z:P1 or ALSV-Z:Hc-Pro, weak
ﬂuorescence was also observed on veins and surrounding
regions, along the margins, and in the apical portion of the
Table 1
Construction of ALSV vaccines against BYMV, ZYMV and CMV.
Target virus ALSV vaccine Nucleotide (nt) positions of target viral
genome inserted into ALSV vector (nt number)
Infectivity a
C. quinoa N. benthamiana Cucumber
BYMV ALSV-BY:P3 3059–3298 (240) þ (þ)
ALSV-BY:P3() 3059–3298 (240) (þ)
ZYMV ALSV-Z:P1 209–418 (210) þ (þ)
ALSV-Z:HC-Pro 1082–1261 (180) þ (þ)
ALSV-Z:P3 3269–3457 (189) þ (þ)
ALSV-Z:CI 3662–3850 (189) þ (þ)
ALSV-Z:NIa 6701–6901 (201) þ (þ)
ALSV-Z:NIb 8321–8521 - (201) þ (þ)
ALSV-Z:CP 8627–8851 (225) þ (þ)
ALSV-Z:CP117 8627–8743 (117) þ (þ)
ALSV-Z:CP66 8678–8743 (66) þ (þ)
ALSV-Z:CP33 8711–8734 (33) þ (þ)
CMV ALSV-C:1a RNA1: 188–385 (188) þ (þ)
ALSV-C:2a RNA2: 313–522 (210) þ (þ)
ALSV-C:3a RNA3: 1494–1733 (240) þ (þ)
ZYMV ALSV-ZC300 ZYMV: 3269–3418 (150) þ (þ)
þCMV CMV-RNA2: 313–463 (150) þ (þ)
a (þ) indicates symptomless infection.
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3rd and subsequent true leaves (Fig. 4A, ALSV-Z:P1-ZYMV
plots).
Accumulation of ZYMV in the 3rd through 6th true leaves of
cucumber 21 days after challenge inoculation with ZYMV-GFP was
evaluated by ELISA. In the wtALSV-ZYMV plot, ZYMV accumu-
lated at a level similar to that in the ZYMV plot in the 3rd through
6th true leaves, whereas in the ALSV-Z:P3-ZYMV, ALSV-Z:Cl-
ZYMV, ALSV-Z:NIa-ZYMV, ALSV-Z:Nib-ZYMV, and ALSV-Z:CP-
ZYMV plots, little accumulation of ZYMV was observed (Fig. 4B
shows the results for the ALSV-Z:P3-ZYMV and ALSV-Z:CP-
ZYMV plots). In contrast, in the ALSV-Z:P1-ZYMV and ALSV-Z:
Hc-Pro-ZYMV plots, approximately half of the accumulation
occurring in the ZYMV and wtALSV-ZYMV plots was observed
(Table 2; Fig. 4B). Examination of the ALSV level in the same
samples resulted in an estimate of the level in the wtALSV-ZYMV
plot, represented by the ELISA value, of approximately twice that
in the wtALSV plot, whereas in the plot with a ﬁrst inoculation
with an ALSV vector vaccine, the accumulation was similar to that
in the wtALSV plot (Fig. 4B). We conﬁrmed that the inserts in ALSV
had been retained in all plants.
Cross protection by ALSV vector vaccines with ZYMV gene fragments
of different lengths
In order to investigate the inﬂuence of the length of the
introduced virus genome fragment on the effectiveness of cross
protection by ALSV vector vaccines, ALSV vectors with 117, 66, or
33 nt in the CP region of ZYMV genome (ALSV-Z:CP117, ALSV-Z:
CP66, and ALSV-Z:CP33, respectively) (Table 1) were produced in
addition to ALSV-Z:CP with 225 nt introduced in the same region,
followed by veriﬁcation of the preventive effect. In the ALSV-Z:
CP-ZYMV plot, no disease symptoms of ZYMV were observed,
whereas in the plots with a ﬁrst inoculation with ALSV-Z:CP117,
ALSV-Z:CP66, or ALSV-Z:CP33, chlorotic and mosaic symptoms
appeared on the leaves, and the smaller the size of the introduced
genome, the greater the severity (Table 2). Similarly, in the plots
with ALSV-Z:CP66 and ALSV-Z:CP33, GFP ﬂuorescence was
observed almost throughout even the 4th and subsequent true
1         2 3 4 5 6 7 8 9
1        2 3        4 5 6 7 8 9
Fig. 3. Symptoms following ZYMV infection on cucumber plants preinoculated
with ALSV vector vaccines (ALSV-Z:P1, ALSV-Z:P3, and ALSV-Z:CP) and an attenu-
ated ZYMV (ZYMV 2002). (A) The 5th true leaves and (B) whole plants challenge-
inoculated with GFP-ZYMV. Photographs were taken 21 days after challenge
inoculation. (1) Healthy; (2) wtALSV; (3) ZYMV 2002; (4) ZYMV; (5) wtALSV-
ZYMV; (6) ALSV-Z:P1-ZYMV; (7) ALSV-Z:P3-ZYMV; (8) ALSV-Z:CP-ZYMV; (9)
ZYMV 2002-ZYMV.
Table 2
Summary of the effects of preinoculation of cucumber plants with ALSV vaccines
against challenge inoculation with GFP-ZYMV.
ALSV vaccines ZYMV symptoms GFP distribution ZYMV accumulation
None þþþ þþþ þþþ
wtALSV þþ þþþ þþþ
ALSV-Z:P1 þ/ þ þ
ALSV-Z:HC-Pro þ/ þ þ
ALSV-Z:P3   
ALSV-Z:CI   
ALSV-Z:NIa   
ALSV-Z:Nib   
ALSV-Z:CP   
ALSV-Z:CP117 þ þ þ
ALSV-Z:CP66 þþ þþ þþ
ALSV-Z:CP33 þþþ þþþ þþþ
þþþ4þþ4þ4þ/4-.
BYMV
ALSV-BY:P3
→BYMV
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Fig. 2. Effects of preinoculation of ALSV vector vaccines [ALSV-BY:P3 and ALSV-BY:
P3()] in N. benthamiana plants against challenge inoculation with BYMV-GFP.
(A) Fluorescence microscopy of the 6th–10th true leaves of N. benthamiana plants
preinoculated with ALSV vector vaccines (ALSV-BY:P3-BYMV and ALSV-BY:P3
()-BYMV) and the control ALSV (wtALSV-BYMV). BYMV was the plot without
pre-inoculation of ALSV vaccine. (B) ELISA of the accumulation of BYMV and ALSV
in the 6th–10th true leaves of N. benthamiana plants as in (A). (C) Northern blot
analysis of the siRNAs derived from BYMV-P3 region in the 6th–10th leaves of N.
benthamiana plants pre-inoculated with ALSV vector vaccines and the control ALSV.
H, healthy control leaves.
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leaves (Table 2). In addition, while a similar level of ZYMV
accumulation in the 3rd through 6th true leaves was not observed
by ELISA in the ALSV-Z:CP-ZYMV plot, ZYMV accumulated in the
ALSV-Z:CP117, ALSV-Z:CP66, and ALSV-Z:CP33 plots (Table 2). The
accumulation of the ALSV vector vaccines was similar in all plots.
Based on these results, we concluded that a virus genome frag-
ment of 180 nt or longer is required to produce a vaccine effect.
Cross protection of ALSV vector vaccines against CMV
First, ALSV vector vaccines against CMV (ALSV-C:1a, ALSV-C:2a,
or ALSV-C:CP) (Table 1) were used as a ﬁrst inoculation of the 3rd–
5th leaves of tobacco (Xanthi-nc) at the ﬁve-leaf stage, and then
CMV-Y was challenge-inoculated into the 7th–9th leaves to assess
the induction of cross protection by each ALSV vector vaccine.
In the experimental plot with no ﬁrst inoculation with ALSV
but inoculated with CMV-Y alone (CMV-Y plot) and in the plot
with the ﬁrst inoculation with wtALSV and the challenge inocula-
tion with CMV-Y (wtALSV-CMV-Y plot), yellow spots were
observed in the inoculated leaves of all individuals approximately
3 days after the challenge inoculation, with severe yellow mosaic
symptoms observed in leaves approximately 7 days after challenge
inoculation (Fig. 5A). In contrast, in the plot with the ﬁrst
inoculation with ALSV-C:2a followed by challenge inoculation
with CMV-Y (ALSV-C:2a-CMV-Y plot), no symptoms were
observed in any of the inoculated individuals (Fig. 5A). In the plot
with the ﬁrst inoculation with ALSV-C:1a followed by challenge
inoculation with CMV-Y (ALSV-C:1a-CMV-Y plot), weak mosaic
symptoms were observed in three of six individuals, but no
disease symptoms appeared in the remaining three individuals.
In contrast, in the plot with the ﬁrst inoculation with ALSV-C:CP
followed by challenge inoculation with CMV-Y (ALSV-C:CP-CMV-
Y plot), weak mosaic symptoms were observed in all six indivi-
duals (Fig. 3A).
No accumulation of CMV-Y in the 12th–15th leaves 9 days
after the challenge inoculation with CMV-Y was detected in the
ALSV-C:2a-CMV-Y plot by ELISA (Fig. 5B). In contrast, in the
ALSV-C:CP-CMV-Y plot, CMV accumulated at a level similar to
that in the CMV-Y and wtALSV-CMV-Y plots. In addition, the
ALSV-C:1a-CMV-Y plot showed approximately one-third to one-
ﬁfth of the viral level of the CMV-Y and wtALSV-CMV-Y plots
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Fig. 4. Distribution and accumulation of challenge-inoculated ZYMV-GFP in
cucumber plants preinoculated with ALSV vector vaccines (ALSV-Z:P1, ALSV-Z:P3,
and ALSV-Z:CP) and wtALSV. (A) GFP ﬂuorescence showing ZYMV distribution on
the 1st–6th true leaves 14 days after challenge inoculation. (B) ELISA of the
accumulation of ZYMV-GFP and ALSV vector vaccines in the 3rd–6th true leaves
of plants 21 days after challenge inoculation. ZYMV was the plot without pre-
inoculation of ALSV vaccine.
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Fig. 5. Effects of pre-inoculation of ALSV vector vaccines (ALSV-C:1a, ALSV-C:2a,
and ALSV-C:CP) in tobacco plants against challenge inoculation with CMV.
(A) Symptoms on tobacco plants 9 days after challenge inoculation with CMV-Y.
(B) ELISA of the accumulation of CMV-Y and ALSV vector vaccines in tobacco leaves
9 days after challenge inoculation. (C) ELISA of the accumulation of CMV-CM42 and
ALSV vector vaccines in cucumber leaves 18 days after challenge inoculation.
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(Fig. 5B). The accumulation of the ALSV vaccine in the ALSV-
C:1a-CMV-Y and ALSV-C:2a-CMV-Y plots was similar to that in
the ALSV and the wtALSV-CMV-Y plots, whereas in the ALSV-C:
CP-CMV-Y plot, it was approximately half to three-fourths of that
in the other plots (Fig. 5B).
Next, effects of the ALSV vector vaccines in cucumber were
investigated using CMV-42CM. In the CMV-42CM inoculation plot
and in the experimental plot with the ﬁrst inoculation with
wtALSV followed by challenge inoculation with CMV-42CM
(wtALSV-CMV-42CM plot), chlorotic spots were observed in the
2nd true leaves of all individuals 3 days after the challenge
inoculation, and chlorotic spots and mosaic were observed in
leaves that developed subsequently (data not shown). In con-
trast, in the ALSV-C:2a-CMV-42CM plot, no disease symp-
toms were observed in any individuals (data not shown). In the
ALSV-C:2a-CMV-42CM plot, disease symptoms were observed in
two of six individuals. In the ALSV-C:CP-CMV-42CM plot, disease
symptoms were observed in all six individuals.
No accumulation of CMV-42CM was found in the ALSV-C:2a-
CMV-42CM plot (Fig. 5C). In contrast, in the ALSV-C:CP-CMV-
42CM plot, accumulation of CMV-42C similar to that in the CMV-
42CM and wtALSV-CMV-42CM plots was observed (Fig. 5C). In
the ALSV-C:1a-CMV-42CM plot, accumulation of CMV-42CM
decreased to approximately half to one-tenth (Fig. 3C). In the
ALSV-C:1a-CMV-42CM and ALSV-C:2a-CMV-42CM plots, ALSV
vector vaccines accumulated to a level similar to that in the
wtALSV plot, whereas in the wtALSV-CMV-42CM plot, accumu-
lation of wtALSV was higher than in the wtALSV plot (Fig. 3C).
ALSV vector vaccines targeting two viral species (ZYMV and CMV)
Cross protection against two viruses (ZYMV and CMV) in
cucumber plants that had ﬁrst been inoculated with ALSV-ZC300
(Table 1) was investigated. As mentioned above, in plants inocu-
lated with only ZYMV or CMV-42CM, or in plots with the ﬁrst
inoculation with wtALSV followed by challenge inoculation with
CMV-42CM, symptoms characteristic of each virus were observed.
In addition, in the ZYMVþCMV and wtALSV-ZYMVþCMV plots,
where a mixture of ZYMV and CMV was inoculated, chlorotic spots
began appearing 6–8 days after inoculation, and two of seven
individuals died 21 days after inoculation, with the remaining ﬁve
individuals showing severe mosaic symptoms over all leaves,
leading to dwarﬁng of the plants (Fig. 6A). In contrast, in the
experimental plots with the ﬁrst inoculation with ALSV-ZC300
followed by challenge inoculation with ZYMV, CMV, or ZYMV
þCMV (ALSV-ZC300-ZYMV, ALSV-ZC300-CMV, and ALSV-ZC
300-ZYMVþCMV plots), no disease symptoms of ZYMV or CMV
were observed in any case (Fig. 6A).
In the ZYMV and wtALSV-ZYMV plots, GFP ﬂuorescence from
ZYMV was observed in the 1st through 5th true leaves, whereas in
the ALSV-ZC300-ZYMV plot, slight GFP ﬂuorescence was observed
on the vein and surrounding area in the ﬁrst and second true leaves,
but no GFP ﬂuorescence was observed in the 3rd or subsequent true
leaves (data not shown). In the ZYMVþCMV and wtALSV-
ZYMVþCMV plots, ﬂuorescence was distributed in the 1st through
5th true leaves. In contrast, in the ALSV-ZC300-ZYMVþCMV plot,
ﬂuorescence was observed in part of the 1st true leaf but not in the
2nd or subsequent true leaves (data not shown).
The accumulation of ZYMV and CMV detected by ELISA was
markedly lower in the ALSV-ZC300-ZYMV, ALSV-ZC300-CMV,
and ALSV-ZC300-ZYMVþCMV plots compared with other plots
(ZYMV, CMV, ZYMVþCMV, wtALSV-ZYMV, wtALSV-CMV, and
wtALSV-ZYMVþCMV plots) (Fig. 6B), which showed that cucum-
ber plants ﬁrst inoculated with ALSV-ZC300 show strong resis-
tance against both ZYMV and CMV.
Curative effects of ALSV vector vaccine on plants with viral disease
Analyses were performed to determine whether cross protec-
tion by an ALSV vector vaccine could be observed in plants either
in the case of simultaneous inoculation with a pathogenic virus
and an ALSV vector vaccine or when the ﬁrst inoculation was with
a pathogenic virus followed by inoculation with an ALSV vector
vaccine. First, ALSV-Z:P3 and a virulent ZYMV (ZYMV-GFP) were
simultaneously inoculated into cotyledons of cucumber seedlings.
No leaf disease symptoms of ZYMV were observed, nor did
dwarﬁng of the plants occur (Fig. 7A co-inoculation plot). GFP
ﬂuorescence indicating replication of ZYMV was observed in parts
of the 2nd and 3rd true leaves but not in the 3rd or subsequent
true leaves (Fig. 7B). Based on ELISA, accumulation of ZYMV was
also markedly suppressed in the 4th and subsequent true leaves
(Fig. 7C).
Next, ZYMV-GFP was inoculated into cucumber cotyledons and
was followed by inoculation with ALSV-Z:P3 into the 1st true
leaves 5 and 10 days later. In the plants inoculated with ALSV-Z:3P,
5 days after inoculation with ZYMV-GFP [ZYMV-ALSV-Z:P3
(5 dpi) plot], no mosaic symptoms appeared in the leaves above
the 4th true leaves (Fig. 7A). In this plot, no GFP ﬂuorescence was
observed in the 4th or subsequent true leaves, and accumulation
of ZYMV was also strongly suppressed (Fig. 7B, C). In the plot in
which plants were inoculated after 10 days [ZYMV-ALSV-Z:P3
(10 dpi)], mosaic symptoms of ZYMV appeared in the 5th and
lower leaves, but no disease symptoms were observed in the
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Fig. 6. Effects of pre-inoculation of cucumber plants with ALSV-ZC300 on challenge
inoculation with a mixture of ZYMV-GFP and CMV-CM42. (A) Symptoms on
cucumber plants. ALSV-ZC300-ZYMVþCMV indicates plants preinoculated with
ALSV-ZC300 followed by challenge inoculation with a mixture of ZYMV-GFP and
CMV-CM42. (B) ELISA of the accumulation of ZYMV-GFP, CMV-CM42, and ALSV
vector vaccines in cucumber leaves 21 days after challenge inoculation.
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upper leaves (Fig. 7A). The higher the leaves on the plant, the
greater the observed reduction in GFP ﬂuorescence and viral
accumulation (Fig. 7B, C). These results revealed that ALSV vector
vaccines can exert a curative effect on virus-infected plants in
addition to offering cross protection against pathogenic viruses.
In order to investigate the mechanism of the curative effect of
ALSV vector vaccines, the distribution of ZYMV and ALSV in the
vicinity of the apical meristem of cucumber plants was analyzed.
Based on ﬂuorescence distribution, ZYMVwas present in the 4th–7th
unexpanded true leaves (Fig. 8A, B) but not around the 9 mm apical
meristem, as shown in Fig. 8A. In addition, in situ hybridization of
shoot apical meristems of cucumber inoculated with a mixture of
wtALSV and ZYMV-GFP revealed that ALSV was distributed in almost
all cells of the shoot apical meristem, whereas ZYMV was distributed
in a portion of the leaf primordium but did not invade the shoot
apical meristem (Fig. 8C).
Discussion
ALSV latently infects most host plants without causing disease
symptoms and induces VIGS homogeneously in the entire plant
(Igarashi et al., 2009; Yaegashi et al., 2007). It is reasonable to think
that infection of plants with an ALSV vector harboring a genomic
fragment of a pathogenic virus apparently induces VIGS against
ALSV-RNA as well as against the pathogenic virus by homology-
dependent resistance against a challenging virus (Ratcliff et al., 1999).
Therefore, it was expected that utilization of the VIGS-inducing
capability of ALSV would allow development of ALSV vector vaccines
with the same function induced by attenuated viruses, potentially
leading to a new control technology for plant viral diseases. To
corroborate this hypothesis, potyviruses (BYMV and ZYMV) and
CMV, important pathogenic viruses in crops, were selected for the
production of ALSV vector vaccines and for analysis of their cross
protection ability.
Two ALSV vector vaccines against BYMV [ALSV-BY:P3 and
ALSV-BY:P3()] effectively inhibit the multiplication and spread
of BYMV in N. benthamiana plants (Fig. 2), indicating that pre-
inoculation with these vector vaccines induces a defense system
against the pathogenic virus, and that the effect is via RNA
silencing, not via any action of the protein derived from the P3
region fragment. This was conﬁrmed by the presence of the siRNAs
in leaves pre-inoculated with ALSV vector vaccines (Fig. 2C). As the
siRNAs detected in leaves infected with ALSV vector vaccines were
derived from BYMV P3-region, ALSV-BY:P3 and ALSV-BY:P3()
could induce a defense response by VIGS to target BYMV P3 region
sequence.
We also produced ALSV vector vaccines into which 7 different
regions of the ZYMV genome had been ligated (ALSV-Z:P1, ALSV-Z:
HC-Pro, ALSV-Z:P3, ALSV-Z:C1, ALSV-Z:NIa, ALSV-Z:Nlb, and ALSV-Z:
CP). Among them, ALSV-Z:P3, ALSV-Z:Cl, ALSV-Z:NIa, ALSV-Z:Nib, or
ALSV-Z:CP induced a strong defense response against ZYMV. On the
other hand, in plants ﬁrst inoculated with either ALSV-Z:P1 or ALSV-Z:
HC-Pro, weak symptoms and GFP ﬂuorescence due to the challenge-
inoculated ZYMVwere observed along with accumulation of ZYMV on
some plants, showing partial cross protection. As ZYMV-GFP ﬂuores-
cence were mainly observed on veins and surrounding regions of the
3rd and subsequent leaves (Fig.4A), defense response might be weak
on leaf veins in plants pre-inoculated with either ALSV-Z:P1 or ALSV-
Z:HC-Pro and allowed the accumulation of ZYMV (Fig.4B). It is not
known why variation in cross protection depended on the genomic
region introduced, though introduction of the 5′ end of the ZYMV
genome (P3 or HC-Pro) may be associated with the weakness of the
protection from the vaccine. The siRNAs were not uniformly distrib-
uted along virus genomes in infected plants and the transgenes in
transgenic plants, but concentrated in hot spots (Donaire et al., 2009;
Leibman et al., 2011; Molnar et al., 2005). This may be also one of the
reason why the strength of cross protection of ALSV vector vaccines
varied depending on the genomic region in ZYMV and also genome
fragments in CMV.
In the plots with a ﬁrst inoculation with wtALSV followed by
challenge inoculation with ZYMV, we always observed that no severe
withering of the plant as found in the ZYMV plot occurred, although
mosaic symptoms were observed in the leaves. We could not explain
the mechanism of this partial cross protection between two quite
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Fig. 7. Curative effect of an ALSV vector vaccine on cucumber plants co-inoculated
with ALSV-Z:P3 and ZYMV-GFP and on plants pre-inoculated with ZYMV-GFP.
(A) Symptom recovery of cucumber plants inoculated with ALSV-Z:P3. Co-inocula-
tion means plants inoculated with a mixture of ALSV-Z:P3 and ZYMV-GFP. ZYMV-
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on true leaves of plants as shown in (A). (C) ELISA of the accumulation of ZYMV-GFP
and ALSV vaccines in leaves of plants 28 days after ZYMV-GFP inoculation.
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different viruses (a cheravirus and a potyvirus). This may be associated
with the phenomenon that the accumulation of wtALSV increased in
all cases (Figs. 4B and 5C), probably by the inﬂuence of the silencing
suppressor (HC-Pro) of ZYMV, similar to the synergism observed in
double infection with ALSV and BYMV (Takahashi et al., 2007).
We examined the effects of the length of the introduced genomic
fragment on the cross protection of ALSV vaccines. ALSV-Z:CP carrying
a 225-nt genomic fragment (CP region) showed strong cross protec-
tion, whereas the shorter the introduced fragment, the weaker the
cross protection by ZYMV in the case of ALSV vaccines carrying 117-,
66-, or 33-nt genomic fragments (Table 2). This result is consistent
with the efﬁciency of an ALSV vector carrying different sized frag-
ments of an introduced PDS gene in inducing silencing in tobacco
(Igarashi et al., 2009). Based on these results, we consider introduction
of a 180 nt or longer gene fragment of a target virus into the ALSV
vector to be necessary for efﬁcient cross protection against a virus. On
the other hand, the expression of the 21-nt small RNAs (sRNAs) is
reported to confer virus resistance on transgenic plants (Qu et al.,
2007). This discrepancy may be due to the expression strategy to
produce sRNAs in plants (transgenic strategy versus virus vector) and
its expression levels (Qu et al., 2007). It is also necessary to compare
the effects of multiple regions of a viral genomewhen producing ALSV
vector vaccines, because cross protection varies depending on the
introduced genomic regions.
In the experimental plots where ALSV-C:2a was inoculated into
tobacco and cucumber, strong cross protection was induced against
CMV-Y and CMV-42CM. In contrast, in the experimental plots with
the ﬁrst inoculation with ALSV-C:1a or ALSV-C:CP, symptoms were
observed in some of the ALSV-C:1a-inoculated plants and mildly in
all the ALSV-C:CP-inoculated plants and the plants with symptoms
supported accumulation of CMV-Y or CMV-42CM. The strength of
cross protection of the vector vaccines was in the order ALSV-
C:2a4ALSV-C:1a4ALSV-C:CP for both CMV-Y in tobacco and
CMV-42CM in cucumber. ALSV-C:CP tended to accumulate less than
other ALSV vaccines (Fig. 5B, C), suggesting one possible reason for its
weak cross protection. The sequence identity between the genomic
region of CMV-Y introduced into the ALSV vector and the corre-
sponding genomic region of CMV-42CM was 90.3%, 98.1%, and 97.9%
in the 1a, 2a, and CP genes, respectively. ALSV-C:2a, which showed
strong cross protection against CMV-Y in tobacco, showed a similar
effect against CMV-42CM. This ﬁnding indicates that designing an
ALSV vaccine harboring a genomic region with a highly conserved
sequence identity allows the expectation of cross protection against
different strains and isolates.
We found that cucumber ﬁrst inoculated with ALSV-ZC300
showed strong resistance in all the experimental plots following
challenge inoculation with only ZYMV, only CMV, or a mixture
of ZYMV and CMV (Fig. 6). Silencing by the ALSV vector is
induced only in the region of tissue where ALSV is present
(Yaegashi et al., 2007), and ALSV labeled with different ﬂuor-
escent dyes shows habitat segregation in the infected tissue
(Takahashi et al., 2007). We accordingly concluded that different
ALSV vector vaccines cannot coexist in the same cell. In view of
these ﬁndings, we cannot expect simultaneous suppression of
multiple viral species in entire plants even if the plant is
superinfected with multiple ALSV vector vaccines, each with
an introduced gene fragment of a viral species. We also found
that introduction of genomic sequences of two viral species into
an ALSV vector, as in ALSV-ZC300, allowed production of an
ALSV vector vaccine capable of suppressing two pathogenic viral
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Fig. 8. Virus distribution on apical tissues of cucumber plant co-inoculated with ZYMV-GFP and wtALSV 12 days after inoculation. (A) GFP ﬂuorescence (left), showing no
distribution of ZYMV-GFP in apical tissue. White arrow indicates GFP spots on an immature true leaf. Right image is a bright-ﬁeld version of the left, in which 4th, 5th, 6th,
and 7th indicate the positions of true leaves shown in (B). (B) GFP ﬂuorescence (upper panel) showing the distribution of ZYMV-GFP in the immature true leaves shown in
lower panel. (C) In situ hybridization analysis of apical meristems of a cucumber plant co-infected with wtALSV and ZYMV-GFP (left) and a healthy control plant (right). ALSV
is distributed uniformly in the apical meristem of an inoculated cucumber plant. In contrast, ZYMV could not invade the meristem tissue. Arrow indicates the presence of
ZYMV in leaf primordium.
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species simultaneously. In transgenic plants, it has been
reported that a single chimeric transgene derived from two
distinct viruses confers multi-virus resistance through
homology-dependent gene silencing (Jan et al., 2000).
There are many cases where production and screening of an
attenuated virus are difﬁcult depending on the target viral species.
For that reason, the practical use of species of attenuated viruses
for control of viral diseases is very limited. In contrast, it may be
possible to produce ALSV vector vaccines that show effects against
many viral species in a short period by changing the introduced
fragments of the viral genome. In addition, we propose the
possibility of producing vaccines targeting multiple viruses simul-
taneously, as demonstrated using ALSV-ZC300.
In this study, we demonstrated a curative effect of ALSV vector
vaccines in virus-infected plants. There are very few reports on the
treatment of virus-infected plants. In one report, tomato mosaic
symptoms that developed following CMV infection were reduced
by inoculation with attenuated CMV containing satellite RNA
(Iwasaki et al., 1998). This result was attributed to that satellite
RNA in the attenuated CMV moved into virulent CMV present in
the infected plant. In this study, it was shown that ALSV can invade
and replicate in the shoot apical meristem of cucumber, whereas
ZYMV could not invade the shoot apical meristem (Fig. 8). As ALSV
distributed in the shoot apical meristem of apple (Yamagishi et al.,
2100; Sasaki et al., 2011) and N. benthamiana plants (unpublished
data), this is an inherent characteristic of ALSV. The multiplication
of ZYMV was suppressed, particularly in upper cucumber leaves in
experimental plots in which a mixture of ZYMV and an ALSV
vector vaccine was inoculated or when the plants were ﬁrst
inoculated with ZYMV followed by inoculation with an ALSV
vector vaccine (Fig. 7). The curative effect of an ALSV vector
vaccine may be due to the establishment of a defense system by
VIGS through prompt invasion of ALSV to the shoot apical
meristem. Once the defense system in the shoot apical meristem
and leaf primordia by ALSV vector vaccine, challenge viruses could
no longer distribute in the tissues of newly developed leaves.
Materials and methods
Construction of ALSV vector vaccines
ALSV vector vaccines containing partial sequence of target viral
genomes were constructed as follows. A 240-nt DNA fragment of the
P3 region in BYMV-RNA was ampliﬁed using two primer pairs
containing Xho I/Bam HI [BYP3-3059Xho(þ) and BYP3-3298Bam
()] and Mlu I/Nde I [BYP3()-3059Mlu(þ) and BYP3()-3059Nde
()] sites (Table 3) and BYMV-based vector (pIbG:FL) (Takahashi
et al., 2007) as template. The DNA fragments were ligated into
pEALSR2mL5mR5 via the Xho I and Bam HI sites and into
pEALSR2mL5mR5-3′MN via theMlu I and Nde I sites. DNA fragments
of ZYMVwere also ampliﬁed using appropriate primer pairs (Table 3)
and an infectious ZYMV cDNA clone (p35S-Z5vectorþGFP-FL) as
template, and ligated into pEALSR2mL5mR5 via the Xho I and Bam HI
sites. ALSV-Z:CP117, ALSV-Z:CP66, and ALSV-Z:CP33 respectively
contained DNA fragments ampliﬁed using primer pairs ZYCP-
8627Xho(þ) and ZYCP-8743Bam(), ZYCP-8678Xho(þ) and ZYCP-
8743Bam(), and ZYCP-8711Xho(þ) and ZYCP-8743Bam(). Simi-
larly, DNA fragments of CMV were ampliﬁed using appropriate
primer pairs (Table 3) and cDNA clones from CYM-Y as template
and ligated into pEALSR2mL5mR5 as above. A chimeric sequence of
ZYMV and CMV genome fragments (150 nt each) were artiﬁcially
synthesized and ligated to pEALSR2mL5mR5.
The vectors thus constructed were puriﬁed from large-scale
cultures of Escherichia coli JM109 using a QIAGEN Plasmid Maxi kit
(QIAGEN, Japan) and then used to mechanically inoculate C. quinoa
plants (Li et al., 2004). After two to three weeks, leaves with
symptoms were homogenized in 3 volumes of extraction buffer
Table 3
Primers used for construction of ALSV vaccines against BYMV, ZYMV, and CMV.
Virus Primern Sequence (5′–3′)nn
BYMV BYP3-3059Xho(þ) TACATCTCGAG3059TCAGGGGCTCAGATAAAAC3077
BYP3-3298Bam() TACATGGATCC3298GGCTATCCTCCTAGCTTCATT3278
BYP3()-3059Mlu(þ) TACATACGAGT3059TCAGGGGCTCAGATAAAAC3077
BYP3()-3059Nde() TACATCATATG3298GGCTATCCTCCTAGCTTCATT3278
ZYMV ZYP1-209Xho(þ) TACATCTCGAG209GCAAGTAGTCGGGTTGGTATA230
ZYP1-418Bam() TACATGGATCC418TCCATTCGGACCCTTTTTCACC397
ZYHC-1082Xho(þ) TACATCTCGAG1082GAAGTCCAGTTCTTTCAAGG1101
ZYHC-1261Bam() TACATGGATCC1261TCTACTAAGTTTCTCCCTAC1242
ZYP3-3269Xho(þ) TACATCTCGAG3269GCGGCGACAAGGGAAGAAAAA3289
ZYP3-3457Bam() TACATGGATCC3457TGCGCCAGCCATGTACAAG3439
ZYCI-3662Xho(þ) TACATCTCGAG3662GATAAGAGACTCACAATTGA3681
ZYCI-3850Bam() TACATGGATCC3850TATTTCATTGGCCACAAAAG3831
ZYNIa-6701Xho(þ) TACATCTCGAG6701AATGAAGGAGATTGCGGATT6720
ZYNIa-6901Bam() TACATGGATCC6901TCCCCACGCGATTTTGCTAG6882
ZYNIb-8321Xho(þ) TACATCTCGAG8321CACACCGAGCTTTTGCAAGA8340
ZYNIb-8521Bam() TACATGGATCC8521TTGTTCAAAGAAGGTATCTT8502
ZYCP-8627Xho(þ) TACATCTCGAG8627GGCTCCGGCTCAGGTGAGAAAA8648
ZYCP-8851Bam() TACATGGATCC8851AGAGGCGAATTGCTGATGAG8832
ZYCP-8743Bam() TACATGGATCC8743CAATGACATTTTCTTTGTGA8723
ZYCP-8678Xho(þ) TACATCTCGAG8678GTGAATGCTGGTTCTCATGG8697
ZYCP-8711Xho(þ) TACATCTCGAG8711CGTCTTTCGAAGATCACAAA8730
CMV CM1a-179Xho(þ) 179AAGACAACTCATGAGCAACTCGAGGAGCAA208
CM1a-385Bam() CGCGGATCC385TAGACAATCGAGAGTTCCACA365
CM2a-313Xho(þ) CCGCTCGAG313GATGAGTTTGTAACTTATGGT333
CM2a-522Bam() CGCGGATCC522TTCAAAACACTTCATGGTTCG502
CMCP-1494Xho(þ) CCGCTCGAG1494AAAATAGACCGTGGGTCTTAT1514
CMCP-1733Bam() CGCGGATCC1733AGATGCAGCATACTGATAAAC1713
n þ; sense prime, ; antisense primer.
nn Restriction sites are underlined and ﬁgures indicate the nucleotide positions of genomic RNA. Accession no.: BYMV;
AB079887, ZYMV; AB188115, and CMV; MCVYRNA1, MCVYRNA2, and MCVYRNA3.
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(0.1 M Tris–HCl, pH 7.8, 0.1 M NaCl, 5 mM MgCl2) and used to
reinoculate C. quinoa plants. The infected leaves were used as ALSV
vaccines for cross protection tests.
Plant materials and cross protection tests
To test the effect of ALSV vector vaccines against BYMV, the 3rd
and 4th true leaves of N. benthamiana at the ﬁve-leaf stage were
inoculated with ALSV vector vaccines or the control ALSV
(wtALSV) using the carborundum method. After 4 days, the 5th
and 6th true leaves of pre-inoculated plants at the seven-leaf stage
were challenge-inoculated with BYMV-GFP by the carborundum
method. The plants were placed into a growth chamber (25 1C,
16:8 h light:dark photoperiod) and used for observation of GFP
and for ELISA 14 days after challenge inoculation.
Cross protection of ALSV vector vaccines against ZYMV in
cucumber was evaluated as follows. ALSV vector vaccines were
used for mechanical inoculation of two cotyledons at the cotyle-
don stage of cucumber with extracts of ALSV vaccine-infected C.
quinoa leaves. Then, ZYMV-GFP (p35S-Z5vectorþGFP-FL) was
challenge-inoculated into the 1st true leaf by a Helios Gene Gun
system (Bio-Rad, Hercules, CA, USA) as described by Yamagishi
et al. (2010) 6 days after ALSV vaccine inoculation. The plants were
placed into a growth chamber (25 1C, 16:8 h light:dark photoper-
iod) for symptom observation. GFP ﬂuorescence of plants was also
observed 14 days after inoculation of ZYMV-GFP using a ﬂuores-
cence microscope. Virus accumulation in cucumber plants was
tested 21 days after challenge inoculation.
For a cross protection test against CMV, ﬁrst, ALSV vector
vaccines were inoculated into the 3rd–5th leaves of tobacco (cv.
Xanthi-nc) at the ﬁve-leaf stage, and then CMV-Y was challenge-
inoculated into the 7th–9th leaves. Because CMV-Y induced no
obvious symptoms in cucumber, CMV-42CM was used to assess
the induction of cross protection in cucumber by each ALSV
vaccine in the same manner as for ZYMV in cucumber.
In all cross protection tests, ﬁve or six plants per experimental
plot were used for each test, and all experiments were repeated at
least twice.
Fluorescence microscopy
N. benthamiana plants inoculated with BYMV-GFP and cucum-
ber plants infected with ZYMV-GFP were observed under a VB-
G25 ﬂuorescent stereoscopic microscope (KEYENCE, Osaka, Japan)
with a GFP ﬁlter set. Digital micrographs were taken using an
Olympus DP70 digital camera (OLYMPUS, Tokyo, Japan).
ELISA
The levels of ALSV vector vaccines, BYMV, ZYMV, and CMV
accumulated in plants were determined with a double-antibody
sandwich (DAS)–ELISA as described previously (Nakamura et al.,
2011). Tissue samples (whole leaves in the case of N. benthamiana
and six leaf discs 1 cm in diameter per leaf of cucumber and tobacco)
were homogenized with 10 volumes (v/w) of PBS-T [137 mM NaCl,
2.68 mM KCl, 8.1 mM Na2HPO4, 1.47 mM KH2PO4, 0.05% (v/v) Tween
20, pH 7.4] containing 2% (w/v) polyvinylpyrrolidone using a
Micro Smash MS-100R cell disruptor (Tomy, Tokyo, Japan). After
centrifugation, the supernatants were incubated overnight in ELISA
plates precoated with virus antisera diluted to 1/1000 (ALSV, BYMV,
and CMV) and 1/500 (ZYMV) at 4 1C. After washing, alkaline
phosphatase conjugate (500 ng/ml) was added and the mixture
was incubated for 3 h at 37 1C. Finally, r-nitrophenylphosphate
(0.67 mg/ml in 10% (w/v) diethanolamine, pH 9.6) was added, and
the absorbance was measured with a Model 550 microplate reader
(Bio-Rad). Antibodies against BYMV and ZYMV were purchased from
the Japan Plant Protection Association (Tokyo, Japan).
Northern blot hybridization
For siRNAs analysis, low molecular weight-RNAs extracted from
of infected N. benthamiana leaves were separated by electrophor-
esis on a 15% polyacrylamide–Tris–borate–EDTA–urea gel and
transferred to a Hybond-Nþ membrane. After UV-crosslinking,
the membranes were hybridized with a DIG-labeled antisense RNA
probe (complementary to positions 2429–3472 of BYMV-RNA).
Hybridization and detection of signals were described previously
(Sasaki et al., 2011).
In situ hybridization
Shoot apices of cucumber plants inoculated with wtALSV and
ZYMV-GFP were sampled, ﬁxed, and embedded in Paraplast Plus
resin (Sigma-Aldrich, St. Louis, MO USA), and tissue sections were
cut and used for in situ hybridization as described before (Sasaki
et al., 2011). DIG-labeled antisense RNA probes complementary to
positions 1465–2090 of ALSV-RNA2 and positions 8882–9382 of
ZYMV-RNA were used for detection of ALSV and ZYMV genomes,
respectively. Hybridization, colorigenic detection, and observation
were performed as described by Nakamura et al. (2011).
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